abstract |
Provided herein are compounds of the formula (I): wherein X, R 1 , R 2 and R 3 are as defined in the specification, as well as pharmaceutically acceptable salts thereof. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment of metabolic diseases and disorders such as, for example, type II diabetes mellitus. |